In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/OioyX30wUG
Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2020 – Feb 2021Where it's discussed
-
X / Twitter7 posts
-
YouTube1 videos
AI synopsis
What people are saying
Discussions generally show a positive attitude toward the publication, with mentions like 'important findings' and references to patient factors affecting inhaler use, indicating recognition of the study's practical implications. The tone is inquisitive but professional, emphasizing the significance of tailoring inhaler choices based on individual patient characteristics.
Most discussions acknowledge the importance of the study, with some mentioning that it confirms prior knowledge or emphasizes clinical relevance.
Postings show moderate interest, often highlighting key findings or mentioning the publication in ways that suggest curiosity about inhaler techniques.
Participants reference specific aspects of the research, such as inhaler resistance and patient factors, indicating active engagement.
Some discussions note that the findings could influence clinical practices or patient management, suggesting a noticeable impact.
Abstract in brief
- The study evaluated how well asthma patients could generate correct peak inspiratory flow rates (PIFR) at different inhaler resistances, finding that most patients can use high-resistance dry powder inhalers (DPIs), but many fail to breathe in fast enough for pressurized metered dose inhalers (pMDIs).
- Key factors influencing PIFR success included gender, age, current inhaler type, and asthma severity, with females and older patients more likely to succeed at high resistance but males and younger patients at low resistance.
- The results suggest that clinicians should consider patient-specific factors when recommending inhalers, as a significant portion of patients, especially those using pMDIs, may not generate optimal inhalation flows, impacting medication delivery.]
Top posts
Most liked on X and BlueskyIn Current Issue! Peak #Inspiratory #Flow #Measured at Different #Inhaler #Resistances in Patients with #Asthma https://t.co/Kxu9SmqQtF https://t.co/xaJDtkha1j
RT @JACIInPractice: In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/Oi…
Peak inspiratory flow measured at different inhaler resistances in patients with asthma. https://t.co/oSgnbyPZWg
RT @JACIInPractice: In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/Oi…
RT @JACIInPractice: In Current Issue! Peak #Inspiratory #Flow #Measured at Different #Inhaler #Resistances in Patients with #Asthma https:/…
All mentions
Asthma Patients' Inhalation Performance with High-Resistance Dry Powder Inhalers
Haughney et al explored how well asthma patients generate peak inspiratory flow rates at different inhaler resistances, highlighting patient-specific factors that influence inhaler efficiency.
RT @JACIInPractice: In Current Issue! Peak #Inspiratory #Flow #Measured at Different #Inhaler #Resistances in Patients with #Asthma https:/…
RT @JACIInPractice: In Current Issue! Peak #Inspiratory #Flow #Measured at Different #Inhaler #Resistances in Patients with #Asthma https:/…
In Current Issue! Peak #Inspiratory #Flow #Measured at Different #Inhaler #Resistances in Patients with #Asthma https://t.co/Kxu9SmqQtF https://t.co/xaJDtkha1j
Peak inspiratory flow measured at different inhaler resistances in patients with asthma. https://t.co/oSgnbyPZWg
RT @JACIInPractice: In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/Oi…
RT @JACIInPractice: In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/Oi…
In Press! #Peak #inspiratory #flow measured at different #inhaler #resistances in patients with #asthma https://t.co/OioyX30wUG